- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03344185
The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day
November 14, 2017 updated by: Matthew Grout
This study provided 24 healthy subjects with two diets that varied in their glycaemic index values.
One condition was a low GI diet, whilst the other was a high GI diet.
Glucose concentrations and mood were measured throughout each test day.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Therefore, the aim of this study is to feed to participants meals which differing in their glycaemic index across the course of a day, and thus produce different glycaemic responses.
The outcome variables will be blood glucose levels and subjective mood.
The purpose of this study is to identify the appropriate times (according to glycaemic response) at which cognitive functioning should be tested.
Importantly, this study is also the first step to characterizing glycaemic and cognitive profiles associated with food consumption over a whole day (breakfast, lunch, snack) rather than just one meal (e.g.
breakfast), ranging from the most favourable (stable glucose regulation) to the least favourable (variability; many peaks and troughs).
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged between 18 and 65 years of age.
- Willing to participate in the entire study (signed informed consent required)
- Subjects will be eligible for the study if male or female (not pregnant or lactating)
Exclusion Criteria:
- Diabetic
- Smoker
- Have any food intolerances or allergies
- History of alcohol or drug misuse
Diagnosed with any of the following:
- High blood cholesterol
- High blood pressure
- Thyroid disorder
- Heart problems, stroke or any vascular disease in the past 12 months
- Inflammatory diseases such as rheumatoid arthritis
- Bone related conditions, such as osteoporosis
- Renal, gastrointestinal, respiratory, liver disease or cancer
- You are presently taking part in another clinical trial or research study
- You are an elite athlete (very high intensity training more than 3 times a week)
- You are currently on a specific diet or taking any dietary supplements and are unwilling to cease during the testing period
- You are intending to regularly use medication which affects gastrointestinal motility
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High GI diet
This diet contained three meals, all with a high GI value.
This was the High Glycaemic Diet intervention.
|
This intervention consisted of three meals, all with a high GI value.
|
Experimental: Low GI diet
This diet contained three meals, all with a low GI value.
This was the Low Glycaemic Diet intervention.
|
This intervention consisted of three low GI meals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Glycaemic profile across the day
Time Frame: Assessed at 0 (baseline), 15, 30, 45, 60, 90, 120 mins after each meal. With 3 meals in a day this totaled 21 assessment point for each day, giving 42 assessment points to compare overall. Data will be reported for the duration of this 3 year PhD award.
|
Change in blood glucose concentrations (mmol/L)
|
Assessed at 0 (baseline), 15, 30, 45, 60, 90, 120 mins after each meal. With 3 meals in a day this totaled 21 assessment point for each day, giving 42 assessment points to compare overall. Data will be reported for the duration of this 3 year PhD award.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mood (alertness, anxiety and contentment) measured by Bond & Lader (1974) Visual Analogue Scale
Time Frame: This was measured 6 times a day (every 90 minutes starting at 0 minutes/baseline), giving a total of 12 times. Each time last approximately 5 minutes, giving a total of 60 minutes overall. Data will be reported for the duration of this 3 year PhD award.
|
The Bond & Lader VAS provides participants with 16 lines measuring 100mm each.
At the ends of each line are two words opposite in meaning.
For example, 'alert' and 'drowsy'.
A participants marks on the line closer to the word they currently feel.
The score from each line is out of 0 to 100.
|
This was measured 6 times a day (every 90 minutes starting at 0 minutes/baseline), giving a total of 12 times. Each time last approximately 5 minutes, giving a total of 60 minutes overall. Data will be reported for the duration of this 3 year PhD award.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel J Lamport, PhD, University of Reading
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
November 9, 2017
First Submitted That Met QC Criteria
November 14, 2017
First Posted (Actual)
November 17, 2017
Study Record Updates
Last Update Posted (Actual)
November 17, 2017
Last Update Submitted That Met QC Criteria
November 14, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2016-032-DL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diet Modification
-
University of Rhode IslandCompletedDiet Modification | Diet HabitUnited States
-
University of ReadingActive, not recruitingDiet Modification | Diet, Healthy | Diet HabitUnited Kingdom
-
University of Rhode IslandBrown University; University of ConnecticutCompletedDiet ModificationUnited States
-
Purdue UniversityCompletedDiet ModificationUnited States
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustCompleted
-
Loma Linda UniversityArdmore Institute of HealthCompleted
-
University Hospital Southampton NHS Foundation...Medical Research Council; University of SouthamptonCompleted
-
Lancaster General HospitalLouise von Hess Medical Research InstituteCompletedDiet Modification | CardiologyUnited States
-
St Mary's University CollegeGoldsmiths, University of LondonUnknownDiet Modification | ADHDUnited Kingdom
Clinical Trials on Low Glycaemic Diet
-
Matthew GroutCompletedMood | Cognitive Performance | Glucose, Low Blood | Glucose, High BloodUnited Kingdom
-
Matthew GroutCompletedDiabetes Mellitus, Type 2 | Cognitive ImpairmentUnited Kingdom
-
Maastricht University Medical CenterUnilever R&DCompleted
-
Chulalongkorn UniversityCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Hospital Authority, Hong KongUnknownDiabetes MellitusChina
-
University of TorontoCanadian Institutes of Health Research (CIHR); Canadian Diabetes Association; Canadian Foundation for Dietetic Research (CFDR)CompletedGestational Diabetes MellitusCanada
-
University of SydneyActive, not recruiting
-
Anne Birgitte RabenCompleted
-
Wageningen University and ResearchCompletedGlucose, Low Blood | Glucose, High BloodNetherlands